Mouse aspartic secretase-1 (mASP1)
US6291223A · kind A · utility
14Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 21, 2000 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Nov 21, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mouse mASP1 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize mouse mASP1. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: Alzheimer's disease, cancer, and prohormone processing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.